SCM
SURF

Suvretta Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Suvretta Capital Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-476,879
Closed -$3.13M – 117
2020
Q2 		$3.13M Buy
+476,879
New +$1.72M 0.07% 61

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Suvretta Capital Management's SURF Position: Q3 2020 in Review

Suvretta Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2020, closing a stake of 476,879 shares — an estimated $3.13M sold.

Suvretta Capital Management first reported a position in SURF in Q2 2020 and held it in 1 quarter. The position peaked at $3.13M in Q2 2020. 59 funds tracked by Wall St. Rank hold SURF as of Q3 2020.

  • Suvretta Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Suvretta Capital Management sold 476,879 Surface Oncology, Inc. Common Stock shares in Q3 2020, an estimated $3.13M.
  • Suvretta Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Suvretta Capital Management's Surface Oncology, Inc. Common Stock position peaked at $3.13M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2020.

Based on Suvretta Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.